(Q35071479)

6 August 2017

1 reference

title

The mouse light/dark box test (English)

1 reference

6 August 2017

1

Michel Bourin

1 reference

6 August 2017

2

Martine Hascoët

1 reference

PubMed ID

12600702

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

European Journal of Pharmacology

6 August 2017

1 reference

6 August 2017

463

1 reference

6 August 2017

1-3

1 reference

6 August 2017

55-65

1 reference

The role of corticotropin-releasing factor in depression and anxiety disorders.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Ketotifen and its analogues reduce aversive responding in the rodent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

PD135158, a CCK-B antagonist, reduces "state," but not "trait" anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Behavioural studies on WAY100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Cholecystokinin as a target for neuropsychiatric drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A schematic representation of the psychopharmacological profile of antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Neurobiology of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic potential of 5-HT3 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Actions of buspirone in a putative model of anxiety in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Exploration of mice in a black and white test box: validation as a model of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic effects of CCK-B antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Exploratory behavior models of anxiety in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Absence of intrinsic antagonist actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Effects of acute and subchronic administration of ritanserin on the social behaviour of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Preclinical profile of the mixed 5-HT1A/5-HT2A receptor antagonist S 21,357.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

5-Hydroxytryptamine pathways in anxiety and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A new approach to the light/dark test procedure in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Influence of Age on Behavioural Response in the Light/Dark Paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A review of the validity and variability of the elevated plus-maze as an animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic-like effect of paroxetine in a rat social interaction test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Ethologically-based animal models of anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic and sedative effects of 5-HT1A ligands, 8-OH-DPAT and MDL 73005EF, in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Evaluation of marble-burying behavior as a model of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Relationship between memory and fear: developmental and pharmacological studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Animal models of ??anxiety??: where next?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The modified light/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic action of CGS 9896 on mouse exploratory behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Cholecystokinin in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

A fully automated light/dark apparatus useful for comparing anxiolytic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Comparison of routes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

Usefulness of animal models with newer anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901274-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(03)01274-3

1 reference

6 August 2017

1 reference

PubMed ID

12600702